CODX Return On Equity from 2010 to 2024

CODX Stock  USD 0.94  0.01  1.08%   
Co Diagnostics Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity will likely drop to -0.43 in 2024. Return On Equity is a measure of the profitability of Co Diagnostics in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.41)
Current Value
(0.43)
Quarterly Volatility
4.3096401
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Co Diagnostics over the last few years. Return on Equity is the amount of Co Diagnostics net income returned as a percentage of Co Diagnostics equity. Return on equity measures Co Diagnostics profitability by revealing how much profit Co Diagnostics generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Co Diagnostics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.5110 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

CODX Return On Equity Regression Statistics

Arithmetic Mean(2.32)
Geometric Mean1.74
Coefficient Of Variation(185.70)
Mean Deviation3.65
Median(0.43)
Standard Deviation4.31
Sample Variance18.57
Range13.4841
R-Value0.67
Mean Square Error11.04
R-Squared0.45
Significance0.01
Slope0.65
Total Sum of Squares260.02

CODX Return On Equity History

2024 -0.43
2023 -0.41
2022 -0.12
2021 0.27
2019 -3.49
2018 5.92
2017 -1.81

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(0.41)(0.43)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.